Michael Hay

New York, New York, United States
Michael Hay has 16 years of financial markets experience and has helped shape Informa Pharma and Healthcare key products: Citeline, Datamonitor, BioMedTracker and Medtrack.

Michael has consulted for numerous top-tier pharmaceutical companies, and worked closely with top healthcare investment firms to provide insight on investment and trading decisions. He is the co-author of the Nature Biotechnology feature Clinical Development Success Rates for Investigational Drugs.

Michael came to Pharma Intelligence through the acquisition of Sagient in 2012, where he had been since 2004. Previously, he worked as a Manager in Thomson Financial’s Capital Markets Intelligence division.

Michael holds a BSc in Finance from the University of Colorado, Boulder (also his home town).
Speaking In
9:00 AM - 9:45 AM (EST)
Wednesday, February 17

A new report on industry clinical success rates will be released at BIO CEO 2021. Join the…